相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis Distinguishing Between Particle Concentration, Type, and Content
Nicholas A. Marston et al.
JAMA CARDIOLOGY (2022)
Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia)
Elisa Waldmann et al.
PLOS ONE (2022)
Society Guidelines 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults
Glen J. Pearson et al.
CANADIAN JOURNAL OF CARDIOLOGY (2021)
Apolipoprotein B and Non-HDL Cholesterol Better Reflect Residual Risk Than LDL Cholesterol in Statin-Treated Patients
Camilla Ditlev Lindhardt Johannesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
Maureen Sampson et al.
JAMA CARDIOLOGY (2020)
The clinical utility of apoB versus LDL-C/non-HDL-C
Ciaran N. Kohli-Lynch et al.
CLINICA CHIMICA ACTA (2020)
The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B
Erwin Garcia et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
Michel R. Langlois et al.
CLINICAL CHEMISTRY (2018)
Discordance between lipoprotein particle number and cholesterol content: an update
Eric P. Cantey et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2018)
Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women
Patrick R. Lawler et al.
CLINICAL CHEMISTRY (2017)
Lipoprotein Insulin Resistance Index: A Lipoprotein Particle-Derived Measure of Insulin Resistance
Irina Shalaurova et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2014)
Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
Seth S. Martin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
P4 medicine: how systems medicine will transform the healthcare sector and society
Mauricio Flores et al.
PERSONALIZED MEDICINE (2013)
Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)
Jennifer G. Robinson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
ApoB versus non-HDL-C: What to do when they disagree
Allan Sniderman et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Translating the A1C assay into estimated average glucose values
David M. Nathan et al.
DIABETES CARE (2008)
Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice
Allan D. Sniderman
JOURNAL OF CLINICAL LIPIDOLOGY (2008)
LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study-Implications for LDL management
William C. Cromwell et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2007)
Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy
Elias J. Jeyarajah et al.
CLINICS IN LABORATORY MEDICINE (2006)
Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk
AD Sniderman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
分享论文
